臨床評價
雷莫盧單抗致腫瘤患者出血風(fēng)險的薈萃分析····································董 勇,于貞貞,司海燕(1):1
替加環(huán)素治療對重癥患者凝血功能的影響·························徐銀麗,祁 慧,江翊國,梁 培(1):6
頭孢呋辛預(yù)防肝硬化食管胃靜脈曲張內(nèi)鏡治療術(shù)后感染的有效性及臨床意義············邱新野,張世斌,李 鵬,郭曉紅,林 陽(2):67
伊伐布雷定治療慢性心力衰竭的快速衛(wèi)生技術(shù)評估···········································周 洋,方振威,門 鵬,翟所迪,石秀錦,林 陽(2):71
多靶點(diǎn)酪氨酸激酶抑制劑安羅替尼的臨床應(yīng)用及安全性評價···········王東曉,朱 曼,唐 上,王 乾,王偉蘭(3):139
小劑量潑尼松聯(lián)合手術(shù)治療肉芽腫性乳腺炎安全性及療效的臨床研究···········朱 強(qiáng),王丕琳,于騰飛,楊自國,霍記平(3):144
VEGFR-2抑制劑雷莫蘆單抗與血栓發(fā)生風(fēng)險關(guān)系的薈萃分析······················································郭二濤,崔紀(jì)麗,武利萍,楊文義,韓大正,王偉蘭(4):213
重組人干擾素α1b霧化吸入治療新型冠狀病毒肺炎的回顧性臨床研究································周 帆,張 瑩,李維亮,趙 燕,趙琳琳,劉 靜,周呈瑞,童 玲,余愛榮(4):218
急性腦梗死患者阿替普酶溶栓出血不良反應(yīng)及影響因素分析···········································郭未艷,呂 娟,王園姬,李亞美,吳松笛,王 芳,藺雪梅(4):222
NUDT15基因多態(tài)性rs116855232與6-巰基嘌呤導(dǎo)致的兒童急性淋巴細(xì)胞白血病白細(xì)胞減少的相關(guān)性研究·································楊玉英,馬紅霞,張小莉(5):287
表柔比星化療的乳腺癌患者心臟毒性的發(fā)生及影響因素的研究······················吳玉婷,陳 穎,朱小麗,朱衛(wèi)忠(5):292
ERCC1基因多態(tài)性與晚期胃癌患者奧沙利鉑化療療效的相關(guān)性研究······················張 倩,湯旭山,朱雅婷,周湘龍(5):295
低劑量普通肝素用于ECMO輔助支持患者抗凝治療的系統(tǒng)評價···········································黃曉婧,趙紅衛(wèi),馬永成,杜鵬強(qiáng),倪 銘,王愛鳳(6):355
實(shí)驗(yàn)研究
基于一測多評法對丁蔻理中丸中6種成分的質(zhì)量控制研究··············································楊 麗,何勝利(1):10
復(fù)方冰甲乳膏長期毒性試驗(yàn)研究···································邱 洪,王 慧,李新順(1):14
達(dá)原飲中芍藥苷和黃芩苷在大鼠體內(nèi)藥動學(xué)研究···································利 玲,胡 秀,利 莉(1):19
359例非透析患者萬古霉素血藥濃度監(jiān)測結(jié)果分析···········································秦 英,張達(dá)偉,石秀錦,李 驍,井浣雨,閆曉昆,林 陽(2):77
參菊洗劑的抗過敏、止癢作用及急性毒性研究···································張廣求,張美祥,譚 璐(2):81
UPLC-MS/MS法測定人血漿中卡馬西平濃度···································張 靜,袁宇琳,熊 雯(2):86
薄荷醇提高臭氧治療大鼠角膜堿燒傷的實(shí)驗(yàn)研究······················夏清平,常 琳,莫艷菲,鄧 麗(3):148
和厚樸酚通過miR-155靶向抑制Smad3及其抑制高糖誘導(dǎo)腎小球系膜細(xì)胞凋亡的機(jī)制研究···········吳琳虹,陳興強(qiáng),張 萌,龍作鵬,陳學(xué)彬(3):152
昆侖雪菊水提物通過AMPK-mTOR通路調(diào)節(jié)INS-1胰島β細(xì)胞自噬的研究············································何 倩,張 之,李鳳祥,唐 瑤,陳 悅,李琳琳,康金森(3):157
HPLC-UV法測定人血漿中替考拉寧藥物濃度的方法學(xué)研究及其臨床應(yīng)用······················································王彥改,沈 芊,蘇,王雪梅,姜德春,閆素英(4):226
357例次替考拉寧血藥濃度監(jiān)測結(jié)果分析···········································蔡 樂,朱 曼,張明華,柴 棟,王東曉,李 芳,李淵源(4):231
顱腦外傷合并側(cè)腦室外引流患者腦脊液中利奈唑胺藥效學(xué)研究···········周 鵬,厲世笑,夏愛曉,林 忠,馬凱昀(4):235
HPLC法測定兒童開胃樂中芥子堿硫氰酸鹽含量·································王歡歡,白 林,黃曉舞(5):299
ICP-MS直接進(jìn)樣測定小兒鈉鉀鎂鈣葡萄糖注射液中11種元素雜質(zhì)含量···········孫濱濱,黃祝剛,賈 佳,鄭琪欣,孟亞楠(5):302
3種常見抗精神分裂藥物的血藥濃度分析···········陳春武,欒 燕,王曾暉,苗彥明,王 爽(6):360
欖香烯乳對小鼠全腦缺血再灌注損傷的神經(jīng)保護(hù)作用·············································趙麗英,鄭 蓓(6):364
反相高效液相色譜法測定人血清中泊沙康唑的濃度···········································計建軍,張 慧,查 麗,費(fèi)愛麗,王小琴,蔡繼明,徐少毅,王長江(6):367
臨床藥師園地
2例高尿酸血癥合并代謝綜合征患者血尿酸達(dá)標(biāo)后降尿酸治療的用藥分析和藥學(xué)監(jiān)護(hù)···································李春杏,劉 樺,紀(jì)立偉(1):24
1例圍產(chǎn)期菌血癥患者的藥學(xué)監(jiān)護(hù)··············································王 雪,姚麗艷(1):29
臨床藥師參與脊柱術(shù)后感染藥物治療的實(shí)踐與體會······················································郭 虎,黃 亮,周繼斌,杜 彪,方 偉,孫秋艷(1):32
1例房間隔缺損并肺動脈高壓患者術(shù)后的藥學(xué)監(jiān)護(hù)···········································黃曉婧,趙紅衛(wèi),馬永成,李亞飛,王愛鳳,王 峰(2):90
1例新生兒耐碳青霉烯類肺炎克雷伯菌合并金黃色葡萄球菌感染的藥學(xué)監(jiān)護(hù)·····························姚 芳,張曉東,阿日貢高娃(2):93
臨床藥師在莫西沙星致QT間期延長不良事件中的實(shí)踐··············································藥 飛,王東曉(2):96
一例青少年復(fù)發(fā)急性髓系白血病粒細(xì)胞缺乏伴發(fā)熱的藥學(xué)監(jiān)護(hù)······················王 穎,尹 鵬,關(guān)麗英,朱 昆(3):162
1例左氧氟沙星氯化鈉注射液致尖端扭轉(zhuǎn)型室性心動過速的用藥分析與藥學(xué)監(jiān)護(hù)·································胡文君,陸 璐,張青霞(3):166
臨床藥師參與一例罕見紋帶棒狀桿菌肺部感染的藥學(xué)實(shí)踐·································劉一鳴,侯繼秋,郭冬杰(4):238
缺血性腦卒中合并慢性腎功能不全患者降糖方案優(yōu)化的藥學(xué)監(jiān)護(hù)························································呂達(dá)娜(4):242
潤燥止癢膠囊致嚴(yán)重肝損傷患者的藥學(xué)監(jiān)護(hù)實(shí)踐······················徐德鐸,惲蕓蕾,陶 霞,劉彥儒(4):246
1例結(jié)核性腦膜炎患者的全程化藥學(xué)監(jiān)護(hù)和用藥分析························································齊曉漣(5):306
1例支氣管曲霉病患者個體化治療的藥學(xué)監(jiān)護(hù)·································郭茂文,朱 曼,姜 楠(5):310
對1例房顫合并心?;颊呗?lián)合使用高強(qiáng)度阿托伐他汀和胺碘酮致橫紋肌溶解的用藥分析與藥學(xué)監(jiān)護(hù)·············································胡文君,張青霞(5):313
從1例CRE肺部感染患者探討碳青霉烯類藥物的延長滴注治療···················王東曉,淳于柳爽,董 立,古 今(6):370
1例機(jī)械性瓣膜置換術(shù)后服用華法林INR異常波動伴反復(fù)牙齦出血患者的藥學(xué)監(jiān)護(hù)·············································彭文星,林 陽(6):375
臨床藥師參與一例大劑量甲氨蝶呤過敏反應(yīng)處理及成功脫敏再應(yīng)用的藥學(xué)實(shí)踐······················孫習(xí)鵬,李星霞,陳 燕,郭 澄(6):378
不良反應(yīng)監(jiān)測
某三級醫(yī)院2015-2018年268例谷紅注射液不良反應(yīng)報告分析························劉 喜,張浩坤,張佳麗,杜重偉(1):34
104例藥物性肝損傷的病例分析···········································王 潔,宋艷艷,李 穎,張江紅,楊新強(qiáng),喬 逸,楊志福,文愛東(1):37
某院2015-2018年441例藥品不良反應(yīng)報告分析···································龐 洋,董海燕,樊 迪(1):41
1230例藥物致過敏性休克不良反應(yīng)報告分析···········································徐元杰,張 晶,郭代紅,趙鵬芝,趙英歌,賈王平(2):99
某三甲綜合醫(yī)院346例抗腫瘤藥物致不良反應(yīng)報告分析······················徐偉佳,高 勇,葉美玲,蔡 林(2):104
9540例帕瑞昔布相關(guān)藥品不良反應(yīng)的自動監(jiān)測研究···········黃翠麗,趙 軒,郭代紅,姚 翀,朱 曼(3):170
氟喹諾酮類致藥物性肝損傷患者的免疫學(xué)及相關(guān)遺傳因素研究···········································楊鴻溢,郭代紅,徐元杰,范 琦,姚 翀,賈王平,孔祥豪(3):174
2016-2019年我院78例伏立康唑藥品不良反應(yīng)報告分析······················程 凱,韓春英,李 娜,劉亞敏(3):179
233例SSRIs和SNRIs類藥物藥品不良反應(yīng)/事件報告分析······················秦娟娟,莊 璐,姚 翀,郭代紅(4):249
110例奧曲肽不良反應(yīng)文獻(xiàn)分析···········孫 寶,白延寧,張媛媛,喬 逸,楊志福(4):253
24例波生坦致不良反應(yīng)文獻(xiàn)分析······················宋兆芮,宋燕青,陶娌娜,李艷嬌(5):317
卡格列凈致正常血糖酮癥酸中毒相關(guān)文獻(xiàn)分析···········································蔡 俊,姚 瑤,劉夢穎,朱巧玲,耿宇宇,李 俐(5):321
456例小金膠囊相關(guān)不良反應(yīng)報告分析···········張 琳,付 娜,魏娟娟,石秀錦,林 陽(5):325
124例藥源性中毒性表皮壞死松解癥不良反應(yīng)病例分析·································郭俊榮,劉 曼,王旭紅(5):329
264例利妥昔單抗超適應(yīng)癥用藥的綜合評價研究···········································王偉蘭,郭代紅,劉思源,朱 曼,姚 翀,謝婷婷(6):381
臨床藥物不良事件主動監(jiān)測與智能評估警示系統(tǒng)Ⅱ的研發(fā)···········································姚 翀,劉東杰,郭代紅,劉思源,孔祥豪,于承暄,朱 雨(6):387
我院康艾注射液ADR集中監(jiān)測研究·································崔海珍,于 倩,王 華(6):391
151例頭孢哌酮類注射劑致過敏性休克的文獻(xiàn)分析······················張 暄,付 婷,吳殿斌,韓瑩旻(6):395
藥物利用分析
內(nèi)鏡切除腸道息肉抗菌藥物預(yù)防性應(yīng)用分析························張 超,劉文影,程 晟,沈 素(1):45
165例EB病毒感染兒童患者的抗病毒藥物應(yīng)用分析························宋 岐,張文銳,宋燕青,王相峰(1):49
649例鹽酸曲美他嗪緩釋片臨床應(yīng)用合理性評價············馮頻頻,趙琴琴,鄭 蓓,王 佩,李功華(1):52
我院重組人促紅細(xì)胞生成素合理性應(yīng)用評價分析······················王 雪,孫 敏,李 靜,司繼剛(2):108
某醫(yī)院2019年亞胺培南西司他丁鈉用藥情況分析······················劉蘭平,陳 媛,藍(lán)紹恒,張炳旭(2):112
急性冠脈綜合征患者抗血小板藥物臨床用藥現(xiàn)狀評價與分析···········································彭文星,石秀錦,徐曉宇,周 洋,張 翼,林 陽(3):182
NSAIDs圍手術(shù)期用藥研究與合理性評價···········陸曉蕾,董 威,陳 猛,沈 斌,何家楊(3):187
40例新型冠狀病毒肺炎治愈患者的藥物治療分析···········································馬慧敏,汪燕燕,談 超,錢芳芳,江小四,戴根苗,夏 泉(3): 191
449例重癥醫(yī)學(xué)科患者鼻胃管給藥的合理性分析······················陸 瑾,俞 云,展冠軍,張東星(4):258
某三級醫(yī)院腫瘤/血液疾病患者碳青霉烯類抗菌藥物臨床應(yīng)用分析······················朱 昆,馬海明,姜東莉,王 穎(4):261
質(zhì)子泵抑制劑在心血管住院患者中的用藥情況及合理性分析······················································石秀錦,嚴(yán) 續(xù),張 翼,陳 曦,許 莎,林 陽(4):264
2016-2019年我院腫瘤中心抗腫瘤靶向藥物使用情況分析·································劉青坡,周麗麗,施振國(5):333
我院靜脈藥物配置中心抗腫瘤藥物使用的合理性分析···········孫曉利,白萬軍,鄭 穎,李 偉,劉 江(5):337
左甲狀腺素鈉片臨床使用情況調(diào)研······················田英超,章 開,曾冰清,湯智慧(5):341
95例住院患者艱難梭菌感染初始用藥分析···········王默然,王文靜,萬里燕,袁麗萍,魏建英(6):399
221例結(jié)核科住院患者利奈唑胺的應(yīng)用分析······················常苗苗,西 娜,趙乙丞,陳 琿(6):403
藥學(xué)服務(wù)
藥學(xué)服務(wù)對糖尿病患者健康管理的影響分析············辛海莉,郭 紅,張 明,袁夢杰,夏 蕾(1):56
定點(diǎn)醫(yī)院藥學(xué)部門應(yīng)對新型冠狀病毒肺炎疫情的策略與效果分析探討·································王 穎,于 倩,朱 昆(2):116
臨床藥師參與3847例會診總結(jié)及典型案例分析···········································張文淵,劉 峰,盧榮枝,黎穎然,劉 威,孫晶晶(2):120
開顱術(shù)后顱內(nèi)感染患者藥學(xué)會診的病例回顧分析···········································郭桂萍,喬 逸,樊婷婷,張 維,王婧雯,楊志福,文愛東(3):195
新型冠狀病毒(COVID-19)疫苗臨床試驗(yàn)監(jiān)督核查模式與時機(jī)的思考與探索···········································儲 藏,王伯陽,高 錦,于蒙蒙,何 為,周蘇萍,朱榮鑫(4):269
臨床藥師主導(dǎo)的PDCA循環(huán)在人血白蛋白合理使用中的應(yīng)用研究································褚燕琦,邢曉璇,李文超,王之舟,程紅勤,張陽鑫,崔曉輝,閆素英,張 蘭(6):408
新型冠狀病毒肺炎疫情期間醫(yī)院藥事服務(wù)實(shí)踐································李 蒙,禹 潔,楊 晨,尚 杰,藍(lán)高爽,謝 棟,李正翔,袁恒杰(6):412
藥學(xué)進(jìn)展
核苷(酸)類似物在妊娠期乙型肝炎患者中的安全性研究進(jìn)展···········································張 楊,殷諾雅,楊仁君,梁小星,王維娜,郭 恒,沈 素(2):123
小檗堿對心血管系統(tǒng)保護(hù)作用及機(jī)制的研究進(jìn)展·············································姜小慶,許長青(4):272
案例分析
阿帕替尼致高血壓、腎病綜合征1例···································袁曉剛,卜永強(qiáng),楊彥偉(1):59
鹽酸安羅替尼致急性心肌梗死1例··············································謝婷婷,王偉蘭(1):62
注射用甘氨雙唑鈉致過敏性休克1例···································邵 丹,于 倩,朱 昆(1):64
伊曲康唑致心力衰竭1例······················孟 超,吳玉琳,鄭雙艷,許寶華(2):128
注射用脂溶性維生素(Ⅱ)/注射用水溶性維生素組合包裝致過敏性休克1例···········黃小理,曾尚勇,楊小葉,黃美虹,王絲靜(2):130
雙膦酸鹽相關(guān)性頜骨壞死1例并文獻(xiàn)分析······················梁錦湄,邢少文,劉靈靈,朱 曼(2):133
1例伏立康唑誘發(fā)精神癥狀的病例分析···········································江 灝,唐 敏,李 薇,楊 戈,劉 耀,何菊英(2):136
氨麻苯美片致尿潴留1例·············································趙慶國,朱 紅(3):199
環(huán)孢素致疼痛綜合征1例及其相關(guān)文獻(xiàn)分析·············································童 玲,余愛榮(3):201
多粘菌素B致急性腎損傷1例······················李洪英,鐘 晗,李漢高,崔 敏(3):204
白癜風(fēng)丸致重度肝損傷1例···········································于 玲,肖 芳,侯繼秋,慕蕭蕭,曲凌萱,陳 康,王冬雪(3): 207
萬古霉素致藥物熱伴血細(xì)胞減少案例分析······················································邱 剛,劉芳琳,張 蕓,宋美琳,李洪英,陳海莉(3):210
阿法替尼致間質(zhì)性肺疾病加重1例·································馮 瑾,惲蕓蕾,侯幸赟(4):276
注射用纖溶酶致惡心嘔吐不良反應(yīng)1例·············································畢鐵琳,邵 丹(4):278
奧司他韋致神經(jīng)精神不良事件2例并文獻(xiàn)復(fù)習(xí)·································祁獻(xiàn)芳,張 磊,孫 俊(4):281
納武利尤單抗注射液致免疫相關(guān)性結(jié)腸炎1例·································劉麗陽,吳志勇,燕 翔(4):284
復(fù)方氨酚烷胺片致血液透析患者腦病1例·································王冬雪,李延玲,侯繼秋(5):345
地塞米松致醫(yī)源性庫欣綜合征1例························································李久旭(5):347
米氮平致不寧腿綜合征1例······················張 偉,宋偉丹,項 露,張小莉(5):350
注射用頭孢曲松鈉致劇烈疼痛1例·············································朱 靜,孫亞東(5):353
曲安奈德外用制劑致醫(yī)源性庫欣綜合征1例·································曾冰清,湯智慧,朱 曼(6):415
環(huán)孢素致間質(zhì)性肺炎1例······················王冬雪,徐 鋒,馬九龍,侯繼秋(6):418
硫辛酸注射液致全身皮疹、水腫1例······················朱 峰,陳 頔,劉曉盈,倪文騏(6):420
硫酸多粘菌素B致患者肢體麻木活動受限······················侯繼秋,曲丹華,王冬雪,朱 曼(6):423
米氮平致高泌乳素血癥·············································章 開,湯智慧(6):425
信 息
臨床評價欄目介紹············································(1):5
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道···································································(1):18
《中國藥物應(yīng)用與監(jiān)測》雜志2020年征訂啟事 ········(1):23
臨床藥師園地欄目介紹·····································(1):28
案例分析欄目介紹···········································(1):44
《中國藥物應(yīng)用與監(jiān)測》稿約 ·····························(1):Ⅰ
臨床評價欄目介紹···········································(2):70
臨床藥師園地欄目介紹·····································(2):89
《中國藥物應(yīng)用與監(jiān)測》雜志2020年征訂啟事 ······(2):103
案例分析欄目介紹·········································(2):115
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································(2):119
《中國藥物應(yīng)用與監(jiān)測》雜志2020年征訂啟事 ······(3):147
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································(3):151
《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明 ·······(3):156
臨床藥師園地欄目介紹···································(3):186
臨床評價欄目介紹·········································(3):190
案例分析欄目介紹·········································(3):198
臨床評價欄目介紹·········································(4):217
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································(4):237
臨床評價欄目介紹 ·········································(5):298
《中國藥物應(yīng)用與監(jiān)測》雜志2021年征訂啟事 ·······(5):328
臨床藥師園地欄目介紹 ···································(5):336
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································(5):344
《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明 ········(5):349
案例分析欄目介紹 ·········································(5):352
《中國藥物應(yīng)用與監(jiān)測》雜志2021年征訂啟事 ······(6):394
《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································(6):398
《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明 ·······(6):407
案例分析欄目介紹·········································(6):411